Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Block Listing Six Monthly Return

2 Jan 2019 07:00

RNS Number : 7694L
Ergomed plc
02 January 2019
 

BLOCK LISTING SIX MONTHLY RETURN

 

 

Date: 2 January 2019

 

Name of applicant:

Ergomed plc

Name of scheme:

Ergomed plc Long Term Incentive Plan

Period of return:

From:

2 July 2018

To:

31 December 2018

Balance of unallotted securities under scheme(s) from previous return:

1,800,000 (original admission)

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

55,000

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

1,745,000

Number and class of securities originally admitted and the date of admission

1,800,000 ordinary shares of 1p each - 2 July 2018

Total number of securities in issue at the end of the period

45,016,438 ordinary shares of 1p each

 

Name of contact:

Nick Blech - Deputy CFO

Telephone number of contact:

+44 (0)7768 547372

 

 Enquiries:

Ergomed plc

Tel: +44 (0) 1483 503205

Stephen Stamp (Chief Executive Officer)

Stuart Jackson (Chief Financial Officer)

 

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black (Broker)

 

Consilium Strategic Communications - for UK enquiries

Tel: +44 (0) 20 3709 5700

Chris Gardner / Mary-Jane Elliott

Matthew Neal / Olivia Manser

 

ergomed@consilium-comms.com

MC-Services - for Continental European enquiries

Tel: +49 211 5292 5222

Anne Hennecke

 

About Ergomed plc

Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing, profitable services offering encompasses a complete suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand, in addition to a full range of high quality contract research and trial management services (CRO). Leveraging its CRO expertise, Ergomed also has a drug development portfolio of co-development partnerships and wholly-owned programmes. For further information, visit: http://ergomedplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRFEWFWAFASEEE
Date   Source Headline
17th Oct 20233:06 pmRNSForm 8.3 - Ergomed PLC
17th Oct 20233:00 pmBUSForm 8.3 - ERGO LN
17th Oct 20232:27 pmRNSForm 8.3 - Ergomed Plc
17th Oct 20231:39 pmGNWForm 8.3 - ERGOMED PLC
17th Oct 20231:23 pmPRNForm 8.3 - Ergomed Plc
17th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) Ergomed Plc
17th Oct 202311:32 amRNSForm 8.3 - Ergomed plc
16th Oct 20234:46 pmRNSHolding(s) in Company
16th Oct 20232:56 pmGNWForm 8.3 - ERGOMED PLC
16th Oct 20231:31 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc - Replacement
16th Oct 202310:59 amRNSForm 8.5 (EPT/RI) - Ergomed Plc
16th Oct 20239:31 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
13th Oct 20234:26 pmRNSResults of Court Meeting and General Meeting
13th Oct 20233:27 pmRNSForm 8.3 - Ergomed PLC
13th Oct 20233:20 pmRNSForm 8.3 - Ergomed plc
13th Oct 20232:35 pmGNWForm 8.3 - ERGOMED PLC
13th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
13th Oct 202311:22 amRNSForm 8.3 - Ergomed plc
13th Oct 202311:14 amRNSForm 8.3 - [Ergomed plc]
13th Oct 202310:37 amBUSForm 8.3 - Ergomed Plc
13th Oct 20239:44 amRNSForm 8.5 (EPT/RI) - Ergomed plc
13th Oct 20238:30 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
13th Oct 20237:00 amRNSForm 8.3 - Ergomed plc
12th Oct 20233:28 pmRNSForm 8.3 - Ergomed PLC
12th Oct 20233:20 pmRNSForm 8.3 - Ergomed plc
12th Oct 20233:16 pmGNWForm 8.3 - ERGOMED PLC
12th Oct 20232:52 pmRNSForm 8.3 - Ergomed plc
12th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
12th Oct 202311:44 amRNSForm 8.3 - Ergomed plc
12th Oct 20239:55 amBUSForm 8.3 - Ergomed Plc
12th Oct 20239:28 amRNSForm 8.5 (EPT/RI) - Ergomed plc
12th Oct 20238:33 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
12th Oct 20237:00 amRNSForm 8.3 - Ergomed plc
11th Oct 20233:23 pmRNSForm 8.3 - Ergomed PLC
11th Oct 20233:20 pmRNSForm 8.3 - Ergomed plc
11th Oct 20233:04 pmRNSForm 8.3 - Ergomed plc
11th Oct 20231:59 pmGNWForm 8.3 - ERGOMED PLC
11th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
11th Oct 202311:26 amRNSIssue of Equity and Rule 2.9 Announcement
11th Oct 202311:17 amRNSForm 8.3 - Ergomed plc
11th Oct 202310:43 amRNSForm 8.5 (EPT/RI) - Ergomed plc
11th Oct 20239:32 amBUSForm 8.3 - Ergomed plc
11th Oct 20237:00 amRNSForm 8.3 - Ergomed plc
10th Oct 20233:58 pmGNWForm 8.3 - Ergomed plc
10th Oct 20231:02 pmPRNForm 8.3 - Ergomed Plc
10th Oct 202312:20 pmGNWForm 8.3 - Ergomed PLC
10th Oct 202311:41 amRNSForm 8.3 - Ergomed plc
10th Oct 202311:00 amRNSForm 8.3 - ERGOMED PLC
10th Oct 202310:03 amRNSForm 8.5 (EPT/RI) - Ergomed Plc
10th Oct 20237:00 amRNSForm 8.3 - Ergomed plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.